GSK3-beta activation is a key driver of resistance to RAF inhibition in BRAF mutant melanoma cells

被引：0
|
作者：
Crisan, D. [1 ]
Scharffetter-Kochanek, K. [1 ]
Zhao, F. [2 ]
Paschen, A. [2 ]
Schatz, S. [1 ]
Hainzl, H. [1 ]
Baican, A. [3 ]
Crisan, M. [3 ]
Basu, A. [1 ]
Sindrilaru, A. [1 ]
机构：
[1] Univ Hosp Ulm, Clin Dermatol & Allerg Dis, D-89081 Ulm, Germany
[2] Univ Hosp Essen, Dermatol Clin, Essen, Germany
[3] Univ Clin Cluj Napoca, Clin Dermatol & Venerol, Cluj Napoca, Romania
来源：
EXPERIMENTAL DERMATOLOGY | 2023年 / 32卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P058
引用
收藏
页码：E30 / E30
页数：1
相关论文
共 50 条
  • [1] LncRNA SAMMSON Mediates Adaptive Resistance to RAF Inhibition in BRAF-Mutant Melanoma Cells
    Han, Shujun
    Yan, Yuwei
    Ren, Yibo
    Hu, Yiming
    Wang, Yan
    Chen, Lei
    Zhi, Zhe
    Zheng, Yan
    Shao, Yongping
    Liu, Jiankang
    CANCER RESEARCH, 2021, 81 (11) : 2918 - 2929
  • [2] Resistance to RAF Inhibition in BRAF Mutant Colorectal Cancer
    Corcoran, Ryan B.
    ONCOLOGIST, 2012, 17 : 2 - 2
  • [3] Unveiling the metabolic response of BRAF mutant melanoma cells to BRAF inhibition
    Delgado-Goni, Teresa
    Wantuch, Slawomir
    Workman, Paul
    Marais, Richard
    Leach, Martin
    Beloueche-Babari, Mounia
    CANCER RESEARCH, 2015, 75
  • [4] MAP Kinase Pathway Alterations in BRAF-Mutant Melanoma Patients with Acquired Resistance to Combined RAF/MEK Inhibition
    Wagle, Nikhil
    Van Allen, Eliezer M.
    Treacy, Daniel J.
    Frederick, Dennie T.
    Cooper, Zachary A.
    Taylor-Weiner, Amaro
    Rosenberg, Mara
    Goetz, Eva M.
    Sullivan, Ryan J.
    Farlow, Deborah N.
    Friedrich, Dennis C.
    Anderka, Kristin
    Perrin, Danielle
    Johannessen, Cory M.
    McKenna, Aaron
    Cibulskis, Kristian
    Kryukov, Gregory
    Hodis, Eran
    Lawrence, Donald P.
    Fisher, Sheila
    Getz, Gad
    Gabriel, Stacey B.
    Carter, Scott L.
    Flaherty, Keith T.
    Wargo, Jennifer A.
    Garraway, Levi A.
    CANCER DISCOVERY, 2014, 4 (01) : 61 - 68
  • [5] ARAF mutations confer resistance to RAF dimer inhibitors in NRAS and BRAF mutant melanoma.
    Malek, Shiva
    CANCER RESEARCH, 2021, 81 (13)
  • [6] TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF-Mutant Melanoma
    Corcoran, Ryan B.
    Rothenberg, Stephen Michael
    Hata, Aaron N.
    Faber, Anthony C.
    Piris, Adriano
    Nazarian, Rosalynn M.
    Brown, Ronald D.
    Godfrey, Jason T.
    Winokur, Daniel
    Walsh, John
    Mino-Kenudson, Mari
    Maheswaran, Shyamala
    Settleman, Jeffrey
    Wargo, Jennifer A.
    Flaherty, Keith T.
    Haber, Daniel A.
    Engelman, Jeffrey A.
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (196)
  • [7] A secondary mutation in BRAF confers resistance to RAF inhibition in a BRAF V600E-mutant brain tumor
    Wang, Jiawan
    Yao, Zhan
    Jonsson, Philip
    Allen, Amy
    Qin, Alice Can Ran
    Uddin, Sharmeen
    Dunkel, Ira J.
    Petriccione, Mary
    Manova, Katia
    Haque, Sofia
    Rosenblum, Marc
    Pisapia, David J.
    Rosen, Neal
    Taylor, Barry S.
    Pratilas, Christine A.
    CANCER RESEARCH, 2018, 78 (13)
  • [8] Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF
    Kim, Jae-Hyeon
    Ahn, Jun-Ho
    Lee, Michael
    CANCER RESEARCH AND TREATMENT, 2017, 49 (04): : 947 - 959
  • [9] Rapid assessment of TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF mutant melanoma
    Corcoran, Ryan B.
    Rothenberg, Stephen M.
    Hata, Aaron N.
    Faber, Anthony C.
    Winokur, Daniel
    Piris, Adriano
    Nazarian, Rosalynn M.
    Brown, Ronald D.
    Godfrey, Jason T.
    Mino-Kenudson, Mari
    Settleman, Jeffrey
    Wargo, Jennifer A.
    Flaherty, Keith T.
    Haber, Daniel A.
    Engelman, Jeffrey a
    CANCER RESEARCH, 2013, 73 (08)
  • [10] HGF mediated resistance to BRAF inhibition in BRAF V600E mutant melanoma xenograft models
    Cooke, Keegan
    Huang, Guo
    Caenepeel, Sean
    Ma, Hong
    Plewa, Cherylene
    Lee, Ki Jeong
    Coxon, Angela
    Hughes, Paul E.
    Beltran, Pedro
    CANCER RESEARCH, 2014, 74 (19)
12345